XML 133 R74.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Details-4) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Beginning balance $ (72,346) $ (40,661) $ (19,216)
Realized and unrealized gains (losses):      
Included in regulatory liabilities (assets) 7,718 (31,685) (21,445)
Included in other comprehensive income 0 0 0
Included in earnings (2,618) (5,005) 868
Included in current assets (108) 0 0
Purchases 23,726 13,370 341
Sales (2) 92 144
Issuances 0 0 0
Settlements (20,998) (8,457) (1,353)
Transfers in and/or out of Level 3 0 0 0
Ending balance (64,628) (72,346) (40,661)
Total gains (losses) included in earnings attributed to the change in unrealized gains (losses) related to assets and liabilities 0 [1] 0 [1] 0 [1]
Purchased Power Expense [Member]
     
Realized and unrealized gains (losses):      
Included in earnings $ (2,618) [1] $ (5,005) [1] $ 868 [1]
[1] MGE's exchange-traded derivative contracts, over-the-counter party transactions, ten-year purchased power agreement, and FTRs are subject to regulatory deferral. These derivatives are therefore marked to fair value and are offset with a corresponding regulatory asset or liability.